Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2025-12-24 @ 6:58 PM
NCT ID:
NCT01414257
Eligibility Criteria:
Inclusion Criteria:
* Patients need to be administered Rheumatrex in order to be enrolled in the survey
* Patients who receive the Rheumatrex at the dose higher than 8 mg/week for the treatment of Rheumatoid Arthritis
Exclusion Criteria:
* Patients who have been treated with Rheumatrex at the dose higher than 8 mg/week since the days when the high dose therapy for RA was not approved
* Patients who have been treated MTX other than Rheumatrex administered Rheumatrex
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
17 Years
Maximum Age:
99 Years
Study:
NCT01414257
Study Brief:
Protocol Section:
NCT01414257